Cpclin Centro de Pesquisas Clinicas

São Paulo, São Paulo 01244-030

0 studies enrolling now · 6 studies all time

What they study most

Axial Spondyloarthritis, Diabetes Type 2, Diabetes, Type 1, Diabetes, Type I, Type 1 Diabetes, Type 2 Diabetes, Type 2 Diabetes Mellitus

Studies at this site

• A Long Term Extension Study of Ixekizumab (LY2439821) in Participants With Axial Spondyloarthritis — Completed
• A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular Risk — Completed
• A 2-Month Safety Follow-Up Trial — Completed
• Efficacy & Safety of Inhaled Insulin in Type 1 Diabetes — Completed
• Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-up — Completed
• Safety and Efficacy of Technosphere® Insulin Inhalation Powder and Lantus® Compared to Humalog® and Lantus® Over 16-Weeks — Stopped early